Astrazeneca (AZN) Net Income (2009 - 2026)
Astrazeneca's Net Income came in at $2.51 billion for Q2 2026, up 2.5% from $2.45 billion a year earlier but down 18.6% from the prior quarter.
Astrazeneca (AZN) Net Income (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Astrazeneca reported Net Income of $10.45 billion, up 25.9% year-over-year; for FY2025, it was $10.23 billion, up 45.3% from FY2024.
- Net Income has increased in each of the last three years, with a five-year compound annual growth rate of 26.6% (FY2020 to FY2025).
- Going back by year, Net Income was $7.04 billion in FY2024 (+18.1%), $5.96 billion in FY2023 (+81.0%), $3.29 billion in FY2022 and $115 million in FY2021 (-96.3%).
- The five-year range for quarterly Net Income is -$1.65 billion (Q3 2021) to $3.08 billion (Q1 2026).
- Year-over-year, Net Income has increased for 11 consecutive quarters, with growth averaging 32.7% over the last eight quarters.
- The fastest year-over-year change in Net Income over five years came in Q2 2023 (growth of 405.6%), and the weakest in Q1 2022 (a decline of 75.2%).
- Business Quant data shows AZN's Net Income at $3.08 billion (Q1 2026), $2.33 billion (Q4 2025) and $2.54 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 1.10 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.51 Bn |
| Mar 31, 2026 | 3.08 Bn |
| Dec 31, 2025 | 2.33 Bn |
| Sep 30, 2025 | 2.54 Bn |
| Jun 30, 2025 | 2.45 Bn |
| Mar 31, 2025 | 2.92 Bn |
| Dec 31, 2024 | 1.50 Bn |
| Sep 30, 2024 | 1.43 Bn |
| Jun 30, 2024 | 1.93 Bn |
| Mar 31, 2024 | 2.18 Bn |
| Dec 31, 2023 | 959.00 Mn |
| Sep 30, 2023 | 1.38 Bn |
| Jun 30, 2023 | 1.82 Bn |
| Mar 31, 2023 | 1.80 Bn |
| Dec 31, 2022 | 902.00 Mn |
| Sep 30, 2022 | 1.64 Bn |
| Jun 30, 2022 | 360.00 Mn |
| Mar 31, 2022 | 388.00 Mn |
| Dec 31, 2021 | -346.00 Mn |
| Sep 30, 2021 | -1.65 Bn |
Astrazeneca Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=AZN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();